Pharmaceutical manufacturing of intermediates and supplements in India.
Annual revenue $10.0M Latest available
Total funding - Funding intelligence
Employees 113 Tracked headcount
Investors - Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Sri Vyjayanthi Labs

Sri Vyjayanthi Labs is a company. The company has 113 employees as of April 05, 2024. Sri Vyjayanthi Labs offers products and services including Glycerophosphates and Glucoheptonates.

  • Employees 113 as on 05 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Legal Name Sri Vyjayanthi Labs Pvt. Ltd.
  • Jurisdiction Visakhapatnam, Andhra Pradesh, India
Operational Areas
Healthcare → Healthcare Products & Supplies Unlock Sub-Sector Unlock Segment
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $10.01 M (USD)
    33.3
    as on Mar 31, 2023
  • Net Profit
    $967.2 K (USD)
    86.32
    as on Mar 31, 2023
  • EBITDA
    $2.03 M (USD)
    86.71
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
    Not available
  • Employee Count
    113

    as on Apr 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Sri Vyjayanthi Labs

Sri Vyjayanthi Labs offers a comprehensive portfolio of products and services, including Glycerophosphates and Glucoheptonates.

Product name locked
Category locked
Primary

Glycerophosphates are manufactured as intermediates for mineral supplements and exports

Product name locked
Category locked
Locked

Glucoheptonates are produced as part of the product line for various applications

Funding Insights of Sri Vyjayanthi Labs

Premium access

Detailed funding history for Sri Vyjayanthi Labs

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Sri Vyjayanthi Labs

Investments
Premium access

Investment portfolio details for Sri Vyjayanthi Labs

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Sri Vyjayanthi Labs

Premium access

Detailed financials for Sri Vyjayanthi Labs

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Sri Vyjayanthi Labs Comparisons

Sri Vyjayanthi Labs Primary company
Description
Pharmaceutical manufacturing of intermediates and supplement...
Location
-
Founded Year
-
Annual Revenue
$10.01 M (USD)
Net Profit
$967.2 K (USD)
EBITDA
$2.03 M (USD)
Employees
113
As of 2024
Premium access

Peer comparison for Sri Vyjayanthi Labs

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Sri Vyjayanthi Labs

Premium access

Detailed competitors of Sri Vyjayanthi Labs

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Sri Vyjayanthi Labs

Premium access

Complete news archive for Sri Vyjayanthi Labs

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sri Vyjayanthi Labs

As of Apr 05, 2024, the latest employee count at Sri Vyjayanthi Labs is 113.

Annual revenue of Sri Vyjayanthi Labs is $10.01M as on Mar 31, 2023.

Sri Vyjayanthi Labs has been operated since 1995, with facilities established in Hyderabad and expanded in 2000. It is recognized as a manufacturer of Glycerophosphates and bulk drug intermediates, adhering to ISO and GMP standards. Exports are conducted to markets including Europe, Brazil, South Africa, Australia, and Mexico. Quality is maintained through compliance with CGMP and environmental guidelines, supported by analytical equipment and experienced teams, ensuring regulatory standards are met in all operations.

Sri Vyjayanthi Labs offers Glycerophosphates and Glucoheptonates.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available